Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents

Fabrice Jourdan, Mathew P. Leese, Wolfgang Dohle, Eric Ferrandis, Simon P. Newman, Surinder Chander, Atul Purohit, Barry V. L. Potter

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The synthesis and antiproliferative activities of analogues of 2-substituted estradiol-3,17-O,O-bis-sulfamates (E2bisMATEs) are discussed. Modifications of the C-17 substituent confirm that an H-bond acceptor is essential for high activity; its optimal linkage to C-17 and the local environment in which it resides are defined. In the non-sulfamoylated series 17 beta-acyl substitution delivers 48b, the most potent compound identified to date. In the sulfamate series a number of permutations of linker and H-bond acceptor deliver excellent activity, with 55, 61, 65, 49a, and 49b proving especially promising. The in vivo potential of these compounds was explored in the NCI hollow fiber assay and also in a mouse Matrigel model of antiangiogenesis in which 49 and 55 show significant inhibitory activity.
Original languageEnglish
Pages (from-to)4863-4879
JournalJournal of Medicinal Chemistry
Volume54
Issue number13
Early online date22 May 2011
DOIs
Publication statusPublished - 14 Jul 2011

Fingerprint

Structure-Activity Relationship
Antineoplastic Agents
Estradiol
sulfamic acid
matrigel

Cite this

Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents. / Jourdan, Fabrice; Leese, Mathew P.; Dohle, Wolfgang; Ferrandis, Eric; Newman, Simon P.; Chander, Surinder; Purohit, Atul; Potter, Barry V. L.

In: Journal of Medicinal Chemistry, Vol. 54, No. 13, 14.07.2011, p. 4863-4879.

Research output: Contribution to journalArticle

Jourdan, F, Leese, MP, Dohle, W, Ferrandis, E, Newman, SP, Chander, S, Purohit, A & Potter, BVL 2011, 'Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents', Journal of Medicinal Chemistry, vol. 54, no. 13, pp. 4863-4879. https://doi.org/10.1021/jm200483x
Jourdan, Fabrice ; Leese, Mathew P. ; Dohle, Wolfgang ; Ferrandis, Eric ; Newman, Simon P. ; Chander, Surinder ; Purohit, Atul ; Potter, Barry V. L. / Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents. In: Journal of Medicinal Chemistry. 2011 ; Vol. 54, No. 13. pp. 4863-4879.
@article{f2531af2e76646cb835c242afacb23b1,
title = "Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents",
abstract = "The synthesis and antiproliferative activities of analogues of 2-substituted estradiol-3,17-O,O-bis-sulfamates (E2bisMATEs) are discussed. Modifications of the C-17 substituent confirm that an H-bond acceptor is essential for high activity; its optimal linkage to C-17 and the local environment in which it resides are defined. In the non-sulfamoylated series 17 beta-acyl substitution delivers 48b, the most potent compound identified to date. In the sulfamate series a number of permutations of linker and H-bond acceptor deliver excellent activity, with 55, 61, 65, 49a, and 49b proving especially promising. The in vivo potential of these compounds was explored in the NCI hollow fiber assay and also in a mouse Matrigel model of antiangiogenesis in which 49 and 55 show significant inhibitory activity.",
author = "Fabrice Jourdan and Leese, {Mathew P.} and Wolfgang Dohle and Eric Ferrandis and Newman, {Simon P.} and Surinder Chander and Atul Purohit and Potter, {Barry V. L.}",
year = "2011",
month = "7",
day = "14",
doi = "10.1021/jm200483x",
language = "English",
volume = "54",
pages = "4863--4879",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "13",

}

TY - JOUR

T1 - Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents

AU - Jourdan, Fabrice

AU - Leese, Mathew P.

AU - Dohle, Wolfgang

AU - Ferrandis, Eric

AU - Newman, Simon P.

AU - Chander, Surinder

AU - Purohit, Atul

AU - Potter, Barry V. L.

PY - 2011/7/14

Y1 - 2011/7/14

N2 - The synthesis and antiproliferative activities of analogues of 2-substituted estradiol-3,17-O,O-bis-sulfamates (E2bisMATEs) are discussed. Modifications of the C-17 substituent confirm that an H-bond acceptor is essential for high activity; its optimal linkage to C-17 and the local environment in which it resides are defined. In the non-sulfamoylated series 17 beta-acyl substitution delivers 48b, the most potent compound identified to date. In the sulfamate series a number of permutations of linker and H-bond acceptor deliver excellent activity, with 55, 61, 65, 49a, and 49b proving especially promising. The in vivo potential of these compounds was explored in the NCI hollow fiber assay and also in a mouse Matrigel model of antiangiogenesis in which 49 and 55 show significant inhibitory activity.

AB - The synthesis and antiproliferative activities of analogues of 2-substituted estradiol-3,17-O,O-bis-sulfamates (E2bisMATEs) are discussed. Modifications of the C-17 substituent confirm that an H-bond acceptor is essential for high activity; its optimal linkage to C-17 and the local environment in which it resides are defined. In the non-sulfamoylated series 17 beta-acyl substitution delivers 48b, the most potent compound identified to date. In the sulfamate series a number of permutations of linker and H-bond acceptor deliver excellent activity, with 55, 61, 65, 49a, and 49b proving especially promising. The in vivo potential of these compounds was explored in the NCI hollow fiber assay and also in a mouse Matrigel model of antiangiogenesis in which 49 and 55 show significant inhibitory activity.

UR - http://www.scopus.com/inward/record.url?scp=79960197643&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1021/jm200483x

U2 - 10.1021/jm200483x

DO - 10.1021/jm200483x

M3 - Article

VL - 54

SP - 4863

EP - 4879

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 13

ER -